The Cone+ makes smoking a pre-rolled joint less harmful
THE NETHERLANDS – With the introduction of The Cone+, Dutch company I-nvention is responding to the growing global trend to filter cannabis smoke. The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP™ filter. This cone shaped filter contains high grade activated carbon made from natural coconut shells, which removes harmful and toxic substances from the smoke.
In addition, the innovation drastically softens the sharp taste of cannabis while smoked, without compromising desired components like CBD and THC, resulting in less coughing and irritation to the throat. The typical taste of natural cannabis seems enhanced after filtration.
I-nvention speaks of a real innovation in the cannabis market. The Cone+ is a logical follow-up of the successful introduction of the CTIP™-filter, used for manual rolling, which the company launched a year ago.
The CTIP™- has a unique cone-shaped recyclable aluminium housing that contains activated carbon that adheres tar and most of the other harmful substances like a magnet. As a result, they do not infiltrate the lungs. Nowadays cannabis connoisseurs are very aware of their health. The trend is that consumers put less or no tobacco in a joint, but cannabis smoke also contains undesirable components when burned. The filter does not get everything out, but in any case makes smoking a pre-rolled joint less harmful, says I-nvention.
The company has designed the filter cone-shaped, allowing consumers to roll a joint more easily if they want to do that themselves. In the pre-rolled The Cone+ the CTIP™-filter is included so consumers or suppliers only need to add cannabis. Based on the successful introduction of the CTIP™-filter, I-nvention says millions of ‘cannabis connoisseurs’ around the world will appreciate and utilize the new invention.
I-nvention is an innovative design and manufacturing company with headquarters in Delft and a division in Shenzhen, China, and Indonesia. The company specializes in innovation in the cannabis retail market. I-nvention became famous when it invented the world’s first electronic joint in 2014.
Licensed clinical Psychologist, Dr. Bethany Cook Shares the Top 7 things to think about before committing and attending family events this 2020 Holiday Season:
Ask Yourself “Is This Good or Bad for My Mental Health?”: Bottom line, if you know a visit to your family will knock you off your “center” the answer is you should not go. We are living in a pandemic for goodness’ sake...some families won’t be able to see one another even if they wanted to due to Covid restrictions. I don’t think going out of your way to visit people you know will significantly upset you is worth the added stress. The fall-out from bad family visits can cause a splash big enough to ripple for weeks before and after the event. Some of the ripple’s effects may include:
Increased self-harm, anxiety, depressed mood, anger, feelings of isolation and suicidal ideation.
Increased levels of cortisol (stress hormone) which may cause muscle weakness, severe fatigue, irritability, difficulty concentrating, high blood pressure, and headache.
Increase in digestive issues such as diarrhea and/or constipation.
Disrupted sleep leading up to and after the gathering.
Ask Yourself “Am I Able to Set a Boundary?”: Many of us are learning for the first time in our lives how to respectfully set boundaries in our relationships with others. Often it’s easier to set them with co-workers and acquaintances because we don’t usually have a past with them like we do with our family members. That being said will you be able to ask your family to respect X? Will they be able to? If they don’t, will you even agree to go? What if they say “yes” and then once you arrive they don’t, what now? (*see #7).
Ask Yourself “Will I Be Able to Enforce My Boundary?”: Setting a boundary is different from enforcing it. Think of it like legislators vs. police. One writes the laws and the other makes sure we obey them. Make sure you and your spouse are on the same page with who will enforce the boundary and how. This can include a tag-team effort. Just make sure going into the event that you are in agreement regarding who does what. Also, what happens if extended family cross the boundary? (*see #7).
Write Up a “Cost/Benefits” Analysis: Allowing and encouraging our child(ren) to have close relationships with extended family members has been the “norm” for generations. Families traditionally have done everything together and wouldn’t have survived without the help of each member. That being said, all types of abuse have also been happening in families since the dawn of time. The abuse can range from severe to mild, physical to emotional. It doesn’t matter the type, it’s not ok on any level. If you are potentially putting yourself, spouse and/or your children into a toxic environment you need to look at who benefits and how much. Sometimes parents who abused their children are wonderful grandparents because they’ve changed and grown. While seeing them may trigger you, you know your child(ren) benefit from seeing and interacting with grandparents and your triggers are manageable. Mentally preparing yourself for the visit and having clear expectations allows you to remain in control and decreases feelings of anxiety.
Ask Extended Family to Agree Not to Bring Politics Up (or any other “hot topic”): I believe in setting people up for success. One of the ways to do that with holiday gatherings this year is to have everyone agree to not bring up certain topics. No, this doesn't make the gathering inauthentic. No, this doesn’t mean we are isolating Aunt Edna because she is the “only one who voted that way.” It means we are showing mutual respect for one another and all agreeing ahead of time to STFU about certain things.
Take Smelling Salts: When we feel threatened we stop using our frontal lobes (judgement, reason, understanding) and instead our thoughts stem from either our limbic system (the emotional center which results in over-the-top impulsive responses) or our cerebellum (survival mode which is flight/fright/freeze). One way to regain control of your thoughts and/or feelings in the moment is to ground yourself using one of your 5 senses. Wear a rubberband on your wrist and when you get irritated “snap” yourself out of it. Take some sour candy and/or black licorice with you and “startle” yourself back to the control center by shocking your taste buds. Lastly, if you do have smelling salts (or strong essential oils) bring them with you and take a whiff to calm down when you start feeling bothered.
Have an Exit Plan: Feeling in control will be the number one “stress reliever” you’ve got which means having a solid exit plan ready to implement if things go sideways. Both you and your spouse need to agree on the exit plan, maybe even have a code word and a prearranged excuse (if you don’t want to have to “get into it” at the moment) for when the plan gets implemented. Talk to your kids about it beforehand so they don’t feel sucker punched. You don’t have to get into the nitty gritty of “why” with them if you don’t want to just give them enough info so they know what to do. This will help you get out faster and with less confusion.
Getting along with family in the best of times can be stressful, but add the stress of a pandemic and a hotly divided political climate and you’ve got yourself a hot mess inside a dumpster fire. That being said, every sword has two sides and the counterpoint we’ve seen is families coming together and getting closer than ever before.
There are no right or wrong answers when it comes to how you manage the upcoming holiday season. My final words of advice are this: you aren’t responsible for making sure everyone in your extended family has a “happy holiday season.” Your first commitment should be to protect the mental health of yourself, spouse and child(ren). It’s ok to hit the “pause” button in relationships. This doesn’t mean you’re a failure and it doesn’t mean you don’t care about the other person. It merely means you are strong and self-aware enough to not set yourself (partner and kid(s)) up for failure. Say's Dr. Bethany Cook.
Health Canada Approves MAVIRET® 8-Week Treatment Duration for Treatment-Naïve Patients with Genotype 3 Compensated Cirrhosis
MAVIRET®(glecaprevir/pibrentasvir) is the only 8-week oral treatment approved for all Hepatitis C virus (HCV) Genotypes.1
MAVIRET is indicated for the treatment of chronic HCV infection in adults and adolescent patients 12 to 18 years of age.1
MAVIRET is available and reimbursed across Canada. **
MONTREAL, Nov. 10, 2020 /CNW/ - AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company announced today that Health Canada has approved a label change for MAVIRET® (glecaprevir/pibrentasvir tablets) to include Treatment-Naïve Genotype 3 patients with compensated cirrhosis.1 With this change, the recommended treatment duration for ALL individuals* with chronic hepatitis C virus (HCV) infection who are treatment naïve, genotypes 1-6 with/or without compensated cirrhosis is 8 weeks.
"I witness the destructive effects hepatitis C has on patients, our community and healthcare system. At the Ottawa Hospital, we see thousands of people on a yearly basis with a variety of liver diseases. Having access to effective HCV treatment options that cover all hepatitis C genotypes is a game changer," said Dr. Curtis Cooper, Director, The Ottawa Hospital and Regional Hepatitis Program. "We now have an opportunity to eliminate this deadly virus with testing, treatment and care in shorter periods of time also available for patients with Genotype 3."
"In 2016, Canada committed on the world stage to eliminate viral hepatitis by 2030. In order to accomplish this important goal, we need population-specific strategies that include equitable access to scaled-up testing and treatment," said, Gerard Yetman, Chair, Action Hepatitis Canada (AHC). "If we want to eliminate hepatitis C in Canada, we need public access to effective treatment options that cover all genotypes."
Health Canada first approved MAVIRET in August 2017. MAVIRET is a once-daily ribavirin-free treatment for adults and adolescent patients 12 to 18 years of age with chronic hepatitis C virus infection across all major HCV genotypes (GT1-6).2 It is an 8-week, pan-genotypic treatment for patients without cirrhosis and who are new to treatment.*
MAVIRET's efficacy and safety were evaluated in nine phase II-III clinical trials, in over 2300 patients with genotype 1, 2, 3, 4, 5 or 6 HCV infection and with compensated liver disease (with or without cirrhosis).1
"AbbVie is committed to eliminating hepatitis C by 2030 and sees this objective as a national public health priority. Through meaningful partnerships, we are working to find sustainable solutions that allow more patients to be screened, linked to care, and treated sooner," said Denis Hello, Vice-President and General Manager AbbVie Canada.
About Hepatitis C An estimated 250,000 people in Canada are living with chronic hepatitis C but as many as 44% are not aware that they have it.3 Left undiagnosed and untreated, chronic hepatitis C can lead to cirrhosis, liver cancer or liver failure. Currently, hepatitis C is the leading indication for liver transplant in Canada.4 AbbVie supports a range of efforts to help elevate and prioritize HCV elimination because we know achieving the shared goal of elimination by 2030 will take more than medicine. It will take transparent and collaborative partnerships with all stakeholders – industry, healthcare providers, healthcare systems, patient groups and their support networks. Joint efforts and maximizing the time we have left will enable us to reach this goal.
About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.caand www.abbvie.com. Follow @abbviecanada on Twitter or find us on Facebook, LinkedIn and Instagram.
* The safety and efficacy of MAVIRET in patients less than 12 years of age have not been established. MAVIRET exposures in HCV-infected patients 12 to 18 years were comparable to those in HCV-infected adults; however, the safety and efficacy of MAVIRET in patients 12 to 18 years infected with HCV genotype 5 or 6 and/or with compensated cirrhosis and/or previously treated with a regimen containing NS5B inhibitor have not been studied.
** Please refer to your province's or Territory's specific reimbursement criteria.
PRO+ Dual Respirator masks now manufactured with ground-breaking virucidal coating against COVID-19
The virucidal coating, produced by ZEN Graphene Solutions Ltd., will increase the protection effectiveness of the PRO+ to 99%
COLLINGWOOD, ON, Nov. 10, 2020 /CNW/ - As the resurgence of COVID-19 activity continues in Canada, Trebor Rx (Trebor) is resolute in providing the highest quality PPE for front line workers. With that commitment in mind, Trebor has signed an LOI with ZEN Graphene Solutions Ltd (ZEN) to commence producing the PRO+ Dual Respirator masks (PRO+ Respirator) with a graphene-based ink with 99% virucidal activity against COVID-19, pending Health Canada approval.
The virucidal graphene-based ink formulation has been tested by Western University's ImPaKT facility Biosafety Level 3 laboratory for antiviral properties in accordance with ISO 18184:2019. The test reported 99% inactivation of the SARS-CoV-2 virus that lasted for 35 days after applying to the masks.
The PRO+ respirator is the only PPE mask that provides 300+ hours of usage at a fraction of the cost of current options, reusable and 99.9% recyclable. The PRO+ respirator, combined with ZEN's virucidal coating, will set a new standard of protection, with 99% effectiveness protecting against viruses like COVID-19. Trebor will be using ZEN's virucidal coating across its different PPE offerings, including its 3-ply surgical masks.
George Irwin, CEO of Trebor, commented, "This is truly a game-changer in the PPE space. Trebor is ecstatic to be working with such an innovative company. It is a pleasure to be partnered with Greg Fenton and Francis Dubé on this journey. With our production on the PRO+ mask already started, and our 3-ply beginning in December of this year, we anxiously await masks' production with the ZEN virucidal coating. Trebor's goal is to deliver a quality Canadian made product, and it just got better with Zen as our partner."
The team behind Trebor, Irwin Toy, has leveraged its robust global supply chain network and global sales expertise to secure commercial interest worldwide for its innovative mask technologies in Canada, the US, Mexico, the Caribbean, South Africa, Australia and New Zealand.
Greg Fenton, CSO of ZEN, said, "This is a historic day for ZEN. The signing of this significant commercial agreement is a watershed moment for our organization. Moreover, it is an honour for ZEN to work with a Canadian company like Trebor to develop a 100% Canadian solution to fight against COVID-19 and provide the highest protection to our front-line workers. It has been an absolute pleasure to work with George, and Brenda Elliott, President of Trebor, throughout this process as Trebor and ZEN share a similar philosophy of innovation. This is only the beginning of what we anticipate will be a long and fruitful partnership."
For more information about the PRO+ Dual Respirator mask and how to procure it, please visit TreborRx.com.
About Trebor Rx Corp.
Fueled by a dedicated and compassionate team prioritizing safety and innovation, Trebor is disrupting the PPE industry and setting a new standard of production for masks and face shields while solving problems of cost, comfort, and medical waste. A proudly Canadian company, founded by business trailblazers George Irwin and Brenda Elliott of Irwin Toy, with a production facility located in Collingwood, Ontario, Trebor is committed to providing Healthcare, Frontline and Essential workers with innovative, new patented technology PPE during COVID-19 and beyond.
About ZEN Graphene Solutions Ltd.
ZEN is a graphene technology solutions company with a focus on the development of graphene-based nanomaterial products and applications. The unique Albany Graphite Project provides the company with a potential competitive advantage in the graphene market as independent labs in Japan, UK, Israel, USA and Canada have independently demonstrated that ZEN's Albany PureTM Graphite is an ideal precursor material which easily converts (exfoliates) to graphene, using a variety of mechanical, chemical and electrochemical methods. ZEN is developing a patent pending graphene-based coating with 99% virucidal activity against COVID-19.
SOURCE Trebor Rx
Former CIO of Niagara Health Sime Pavlovic joins CGI
Toronto, Ontario, 10 November, 2020 –CGI (NYSE: GIB) (TSX: GIB.A) is pleased to announce that Sime Pavlovic has been appointed as Vice-President, Consulting Services, Ontario Public Sector, Healthcare, Transportation & Regulatory. Previously Mr. Pavlovic was Chief Information Officer of Niagara Health, responsible for information, communications and technology strategy.
An experienced executive with demonstrated leadership and over 20 years of experience in the Ontario public sector, Mr. Pavlovic specializes in healthcare, service delivery and enterprise architecture. His goal has always been simple, to implement strategies that advance innovation in improving the delivery of services to citizens.
“I am thrilled to be a member of a Canadian company with a history of demonstrated excellence in the public sector,” says Mr. Pavlovic. “CGI has incredible subject matter expertise including global centres of excellence that support our clients in advancing their digital strategies.”
Mr. Pavlovic’s strategic objectives will include leveraging innovation from other sectors, showcasing CGI’s demonstrated expertise in assisting clients with implementing their vision and transforming public and healthcare systems to provide the most value. His role in achieving these objectives will include providing strategic leadership during the transformational process and translating client ideas and strategy into practical implementations.
“Sime brings to CGI a wealth of experience and relationships across the Ontario public sector,” says Dave Cameron, Senior Vice-President, Greater Toronto Commercial and Public Sector. “He is a recognized leader in delivering innovative solutions including patient care & experience, supply chain, human resources, digital imaging and digital identity.”
CGI is a leader in working with provincial health organizations, health regions, and hospitals to harness the power of technology to improve the quality of care, while at the same time managing costs and enhancing productivity. With over 5,000 health IT professionals globally, and 500 nationally, we are recognized as one of the largest consulting, systems integration, and outsourcing service providers in the Canadian healthcare sector.
About CGI Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 77,500 consultants and other professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. With Fiscal 2019 reported revenue of C$12.1 billion, CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at cgi.com.
For more information: Media Sébastien Barangé Vice-President, Media and Public Relations sebastien.barange@cgi.com +1 514-841-3354
Sime Pavlovic, ancien chef de la direction informatique de Santé Niagara, se joint à CGI
Toronto (Ontario), le 10 novembre, 2020 – CGI (NYSE : GIB) (TSX : GIB.A) est heureuse d’annoncer la nomination de Sime Pavlovic à titre de vice-président , services-conseils, secteur public de l’Ontario, santé, transport et réglementation. M. Pavlovic était chef de la direction informatique à Santé Niagara; à ce titre, il était responsable de l’information, des communications et de la stratégie technologique.
Comptant plus de 20 ans d’expérience dans le secteur public en Ontario, M. Pavlovic se spécialise en santé, en prestation de services et en architecture d’entreprise. Un dirigeant d’expérience faisant preuve d’un solide leadership, son objectif est simple : mettre en œuvre des stratégies qui stimulent l’innovation pour améliorer la prestation de services auprès des citoyens.
« Je suis ravi de me joindre à une entreprise canadienne qui, au fil des ans, a fait preuve d’excellence dans le secteur public, affirme M. Pavlovic. La grande expertise de CGI et ses centres mondiaux d’excellence permettent aux clients de faire progresser leur stratégie numérique. »
Parmi ses objectifs stratégiques, M. Pavlovic tirera parti de l’innovation des autres secteurs et mettra en valeur l’expertise éprouvée de CGI pour aider les clients à réaliser leur vision et à transformer les systèmes du secteur public et de la santé de façon à créer le plus de valeur possible. Pour atteindre ces objectifs, il devra faire preuve de leadership stratégique pendant le processus de transformation et traduire les idées et la stratégie du client en mises en œuvre concrètes.
« Sime apporte à CGI une vaste expérience et un réseau de contacts dans le secteur public de l’Ontario », a déclaré Dave Cameron, vice-président principal, région du Grand Toronto, services commerciaux et publics. « Il est reconnu pour son leadership dans la livraison de solutions innovantes, notamment en soins aux patients et expérience du patient, en chaîne d’approvisionnement, en ressources humaines, en imagerie numérique et en identité numérique. »
En partenariat avec les organismes provinciaux de santé, les agences régionales de santé et les hôpitaux, CGI tire parti de la puissance des technologies afin d’améliorer la qualité des soins tout en gérant les coûts et améliorant la productivité. Comptant plus de 5 000 professionnels en TI dans le secteur de la santé partout dans le monde (dont 500 au Canada), nous sommes reconnus comme l’une des plus importantes entreprises en services-conseils, intégration de systèmes et services en mode délégué dans le secteur de la santé au Canada.
À propos de CGI Fondée en 1976, CGI figure parmi les plus importantes entreprises indépendantes de services-conseils en technologie de l’information (TI) et en management au monde. CGI compte 77 500 conseillers et autres professionnels établis partout dans le monde grâce auxquels l’entreprise offre un portefeuille complet de services et de solutions : des services-conseils stratégiques en TI et en management, de l’intégration de systèmes, des services en TI et en gestion des processus d’affaires en mode délégué ainsi que des solutions de propriété intellectuelle. La collaboration de CGI avec ses clients repose sur un modèle axé sur les relations locales, conjugué à un réseau mondial de prestation de services, qui permet aux clients de réaliser la transformation numérique de leur organisation et d’accélérer l’obtention de résultats. Au cours de l’exercice financier 2019, CGI a généré des revenus de 12,1 milliards de dollars canadiens. Les actions de CGI sont inscrites à la Bourse de Toronto (GIB.A) ainsi qu’à la Bourse de New York (GIB). Apprenez-en davantage sur cgi.com.
CORDANT HEALTH SOLUTIONS AND ADDICTION LEADERS IN TENNESSEE DISCUSS THE IMPORTANCE OF CARE COORDINATION FOR ADDICTION TREATMENT PATIENTS
Cordant Health Solutions®, a leader in providing innovative tools for patients in addiction treatment programs, announced its new pharmacy location in Nashville in a digital open house. Cordant’s managed pharmacy program serves patients in treatment for opioid use disorder using medication-assisted treatment (MAT).
Treatment providers across Tennessee joined in Cordant’s open house to listen to two local providers talk about barriers to recovery. Victor Wu, MD, MPH, chief medical officer for TennCare, spoke about the need for more care coordination services to help people cope with a disease that thrives in isolation.
"If you can't get to your appointment, or you're not able to get to the pharmacy, then those can be system challenges that might trip you up and cause you to stop your treatment, even though you have the desire and the will to stay in recovery," said Wu.
Although picking up a prescription sounds like a simple errand, if you are a MAT patient receiving medication as part of your addiction therapy, it can be anything but simple, even though it significantly reduces cravings and withdrawal symptoms.
"Unfortunately, access to this medication is often a significant barrier for patients in recovery. Patients feel stigma or judgment when they pick up these medications or worry about a lack of privacy," said Bob Mann, executive vice president at Cordant. "Not all pharmacies carry or are willing to dispense medicines that treat addiction. And finding transportation to a pharmacy that carries addiction treatment medications is yet another obstacle."
Roger Sherman, MD, owner of Compassionate Recovery Care, also spoke at the open house about his recovery patients' challenges. "I’ve come to believe we need to meet patients where they’re at, not just physically but emotionally."
As Tennessee weathers the COVID-19 pandemic, state officials report that the opioid epidemic has intensified. Health officials in Shelby County, Tennessee’s largest by population, say the number of overdoses related to opioids and other drugs escalated this spring, with 391 suspected overdoses and 58 overdose deaths over 30 days.
In response to these kinds of challenges, Cordant developed a managed pharmacy program to deliver buprenorphine, a common addiction treatment medication, to treatment clinics at no extra cost to the patients or the clinician. Patients attending support group meetings or treatment visits can also pick up their medications from the Cordant coordinator at the clinic.
"Cordant’s pharmacy program helps patients reclaim their lives, removes very real barriers to their success in treatment and helps them return to a productive life," said Mann. "Data from the pilot study of our managed pharmacy program shows that patients using our service were 32% more likely to keep their appointments, had 44% fewer relapse events and had 43% fewer drug-related visits to emergency departments compared with a control group. Perhaps most significant, patient retention increased 52%, particularly in the first six months of treatment, when patients are often in the most vulnerable stage of recovery."
Cordant’s Tennessee location is its sixth pharmacy, and the program has served 10,000 patients in 2020.
"So many of my patients have concerns about going to a local or traditional pharmacy because they worry about seeing someone they know. They've gone through such a tough, traumatic life, and anything we can do to show them compassion and give them some privacy when it comes to their treatment, I think, is important to their success and their ability to beat this disease," said Sherman. "Offering Cordant’s managed pharmacy program to my patients has certainly increased success rates and decreased relapse rates in my clinic."
Cordant Health Solutions® (cordantsolutions.com) provides innovative tools for monitoring behavioral health, chronic pain and criminal justice cases. Cordant’s unique pharmacy and drug testing programs provide accurate, actionable results to protect prescribers, hold patients accountable and optimize quality of life.
A leader in quality standards, Cordant provides solutions for payers, clinicians and organizations involved with substance use disorder, pain management and criminal justice agencies. Cordant is one of the only healthcare companies that offers monitoring and risk assessment tools through its innovative drug testing options and full-service, high-touch pharmacies, which specialize in the management and dispensing of addiction treatment medications. Cordant’s testing protocols and digital case-management tools help clients become more efficient and effective in using drug testing programs to monitor patient adherence, reduce risk and improve patient outcomes.
Courageous Kids Must Save Santa in Time for Christmas
New York, NY, November 10, 2020 — Amid the backdrop of an overindulgent culture and waning Christmas spirit, one company, Eastern Industries, is uniquely poised to monopolize the attention of children with the launch of its latest video game. But things have gotten way out of hand. Santa is missing, the North Pole is in a state of chaos, and Christmas may not happen at all! With the holiday traditions of the world hanging in the balance, can a team of intrepid youngsters drawn from the Naughty List, some toy soldiers and living snowmen save the day?
Author Thomas Conway sets the stage for worldwide adventure in The Naughty List, his imaginative, modern Christmas tale that blends elements of pop culture with the age-old tradition of Santa Claus. The story begins at a Macy’s Thanksgiving Day parade without Santa, where toy manufacturer Eastern Industries has just released a new holiday marketing scheme, which keeps kids glued to their devices and drains everyone’s holiday spirit. With Christmas fast approaching and Santa nowhere in sight, a team of daring youngsters recruited from Santa’s Naughty List aim to rescue Santa and save the holiday.
While primarily a Santa tale, The Naughty List cleverly incorporates Winter holiday beliefs from around the world, including the legend of Marduk, a Babylonian god; the Roman feast of Saturnalia; the epic story of Jangar from North Asia; Moravian traditions of animal communication; and the present real-life adventures of Israeli Santa Claus, Nicola Abdou.
Also sprinkled with references to holiday favorites such as Miracle on 34th Street, T’was the Night Before Christmas, Rudolph the Red-Nosed Reindeer and others, this wonderfully rich tale promotes right over wrong, good over evil and love over fear.
Suitable for all ages, The Naughty List skillfully weaves valuable lessons about overindulgence and society’s tendency to put labels on children, with the overarching theme that when kids misbehave they should not be defined by their bad deeds but rather see it as a learning opportunity, since when we appreciate the best in humanity and combine our talents, we are capable of almost anything.
The Naughty List, winner of the 2020 Indie Book Award in the E-Book Fiction category, is the first release from Thomas Conway. His 30-year career spans various industries. When not at work, he devotes his time to environmental matters and inventing stories for his two children.
No. 1 Bestselling M.D. Reveals Ultra-Rapid, Drug-Free Techniques to Overcome Anxiety and Depression
San Francisco, CA, Nov. 10, 2020 — Numerous recent surveys indicate that depression and anxiety have doubled or tripled since the corona pandemic. In fact, according to the CDC, more than 40 percent of the population are experiencing “adverse mental conditions . . . associated with . . . Covid-19.” Top that with the realities of the pandemic—including fear of death, separation from loved ones, loss of employment, and intense political battles that trigger even more emotional vulnerability and despair. Now, world-renowned psychiatrist, Dr. David D. Burns, brings us a radical new approach to healing in his No. 1 Amazon bestselling book, Feeling Great: The Revolutionary New Treatment for Depression and Anxiety (PESI, Inc., ISBN: 9781683732884;$26.99, Hardcover). Selling more than 29,000 copies in the first two weeks since its release, Feeling Great reveals innovative techniques that make rapid change possible, even without drugs or therapy.
Feeling Greatemerged from 40 years of research and more than 40,000 hours treating individuals with severe depression and anxiety. This research revealed that negative feelings do not result inwhat’s WRONG WITH YOU—like a chemical imbalance in your brain or a “mental disorder”—but from what‘s RIGHT WITH YOU. And the moment you realize this, recovery will be just a stone’s throw away.
Dr. Burns’ Feeling Good and Feeling Good Handbook have sold more than 5 million copies and have made cognitive therapy the most popular and most extensively researched form of therapy in the world. More than 50 percent of depressed people who read Feeling Good recover of improve dramatically in four weeks with no other treatment. The techniques in Feeling Great are even more powerful.
In Feeling Great you will:
1. Learn how to change the way you think and feel;
2. Pinpoint and eliminate the powerful forces that keep you stuck; 3. Discover why depression and anxiety are the world’s oldest cons; 4. Crush the 10 types of distorted thoughts that rob you of happiness and self-esteem.
Feeling Great feels wonderful! You owe it to yourself to feel GREAT!
David D. Burns, M.D., is an Adjunct Clinical Professor Emeritus of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. His Feeling Goodand Feeling Good Handbook have sold more than 5 million copies worldwide. His weekly Feeling Good Podcasts are approaching three million download, and more than 50,000 mental health professionals have attended his workshops throughout the United States and Canada. Dr. Burns lives in the San Francisco Bay area. To learn more, visit www.feelinggood.com and www.FeelingGreattheBook.com.
In Second Edition of His Book Covid-19, California Physician Maintains Trump’s Approach to Pandemic Is Correct
President Trump’s approach to dealing with Covid-19 is on the right track, according to the author of Covid-19: A Physician’s Take on the Exaggerated Fear of the Coronavirus. The second edition of the book was released today.
Dr. Jeffrey I. Barke, a family physician based in Newport Beach, Calif., with more than 25 years of medical practice, writes that governmental reaction to the Covid-19 pandemic — shutting down businesses, curtailing organizations, stopping gatherings, shuttering schools, requiring face masks and urging social distancing — is causing an unnecessary self-inflicted wound to the U.S. economy and way of life.
The book’s first edition, released on Sept. 16, sold so quickly that a second edition, expanded by more than 40%, was rushed into production. The revised edition appears as the U.S. is experiencing a third wave of infections. Once again, the question of how best to respond to the epidemic tops the blogs, cable news shows and many newspaper columns, and was a key issue in the Presidential election.
In the second edition, Barke expands on the latest scientific studies to refute the common wisdom of how best to protect the population from the disease.
“There is no doubt that Covid-19 is a dangerous virus to the elderly and frail," Barke writes. “But the fact is that the overall reaction . . . has caused more harm than the virus itself.” He cites the economic and emotional turmoil caused by closing down businesses and schools as well as the almost complete shutdown of the country’s outpatient healthcare system. When the history of this pandemic is written, Barke predicts, it will show that our reaction to the virus was a great mistake. “If you are young and healthy, you have nothing to fear from the coronavirus except the fear-mongering from the media.”
Barke dismisses the value of wearing a typical protective mask, which he notes can filter no objects smaller than 3 microns in diameter. “A 0.12 micron Covid-19 virus particle will pass through an ordinary surgical mask . . . It is the equivalent of erecting a chain-link fence to keep out mosquitoes.”
He also notes that the expected final fatality rate of the Covid-19 pandemic will be around 0.2%, which “is in the ballpark of a bad influenza season.”
Barke adds, “A healthy society protects its most vulnerable members and isolates [only] the sick while allowing the healthy individuals to go about their lives.” Much of the U.S. has done the reverse by taking huge and intrusive steps to protect the healthy against the few who are sick.
His book’s foreword was written by Dennis Prager, the noted political commentator and radio and television talk show host. Barke has guested with Prager several times as well as with Larry Elder, another prominent radio personality who endorses the book in these words: “Great collection of eye-opening, thought-providing essays.”
In the book’s introduction, the publisher acknowledges that some of the author’s ideas are controversial. He urges readers to “keep an open mind” while considering Barke’s views and notes George Bernard Shaw’s famous admonition that “those who cannot change their minds cannot change anything.”
Covid-19: A Physician’s Take on the Exaggerated Fear of the Coronavirus, 2nd Edition
The Americas Group, 520 S. Sepulveda Blvd., Suite 204, Los Angeles CA 90049-3534 www.AmericasGroup.com
PRESIDENT-ELECT BIDEN NAMES CORONAVIRUS ADVISORY BOARD, URGES ALL AMERICANS TO WEAR MASKS, MASK MANDATE MAY FOLLOW
BENEFITS OF “MyGO2Mask” FACE MASK WITH PATENTED
GRAPHENE OXIDE TECHNOLOGY THAT DESTROYS COVID-19 AND FLU DROPLETS NOW MORE IMPORTANT THAN EVER
Delray Beach, FL—November 10, 2020 G-MASKS, LLC, www.g-masks.comthe importer of face masks from South Korea that provide the highest levels of filtration, absorption and boast anti-viral and bacteriostatic qualities, today announced its support for President-elect Biden’s indication that a national mask mandate may be in the offing.
“Please, I implore you, wear a mask,” President-Elect Joe Biden said. “We can save tens of thousands of lives if everyone would just wear a mask. Do it for yourself, do it for your neighbor.” He continued, "Wearing a mask seems like a small act. Maybe you think your individual choice won’t make any difference. Throughout our history, throughout the history of our nation, we’ve seen over and over how small acts add up to enormous achievements. It’s the weight of many small acts together that bend the arc of history.”
MyGO2Mask, www.mygo2mask.us, is a 4-ply, super high-quality graphene-oxide coated face mask that traps 99.53% of particles at a size of .3 nanometers or smaller, including Covid-19 virus droplets and flu particles. MyGO2Mask has earned multiple certifications and registrations and is the only face mask that can trap and destroy Covid-19 virus droplets in less than two minutes after contact.
“As Covid-19 infections rise in the US and across many geographies, wearing a mask has become an integral aspect of the protection protocol. President-elect Biden plans on moving toward a national mask mandate and we are ready to supply what we believe is the most effective mask at stopping the virus in its tracks to those who want the best protection,” said William Sackett of G-MASK, LCC. “MyGO2Mask has already received multiple certifications and registrations and uses the highest quality graphene oxide. Scientific studies show it truly works.”
MyGO2Mask features the highest quality anti-viral, anti-bacterial grapheme oxide from South Korea used in a patented process to create an affordable, reusable and washable mask that blocls 99.53% of particles .3 nanometers or smaller destroying virus droplets in minutes, superior to supposed the supposed gold standard N-95 mask.
(MyGO2Mask features superior filtration capabilities. Coronavirus particles are measured between .07 and .09 microns. While N95 masks filter 95-99% of particles, it only filters particles larger than 0.1 microns. MyGO2Mask’s graphene oxide filters 99% of particles measuring .3 nanometers or smaller making it virtually impenetrable. (i.e. average human hair measures 75 microns which is 1000x’s larger than a single nanometer) . Simply put, the MyGO2Mask provides ideal Coronavirus filtration and the ability to destroy the virus and flu almost on contact whereas the N95 mask does not.)
Numerous independent studies have shown that graphene oxide helps repel and “potentially kill or destroy” different types of viruses containing what scientists call microdroplets. According to studies done on graphene at MIT and Hong Kong’s Polytechnic University, the material is referred to as “superhydrophobic” that reduces the chance of infectious droplets adhering to it and according to experts, “rips coronavirus apart.” The following link discusses the special properties of high-quality graphene oxide:
Additionally, the outlet Sci-Tech Daily reported as recently as September 13, 2020 that, “Graphene’s sharp edge damages the bacterial cell membrane and kills the virus. It may also be killed by the hydrophobic (water repelling) property of graphene.”
In comparison to the 99.53% filtration of particles sized .3 nanometers or smaller achieved by the MyGO2Mask, an N95 mask, which until now was considered the gold standard, only filters 95-99% of particles sized 0.1 microns. The result is that the MyGO2Mask has substantially increased particle-filtering properties. As important, the MyGO2Mask is the only mask capable of destroying virus droplets. Virus droplets are not destroyed by the N95 mask and remain alive when the mask is touched leaving the potential to continue virus spreading. Many experts agree that how you handle your mask is almost as important as wearing your mask because of the concern about spread.
Every MyGO2Mask is shipped hermetically sealed and features a unique and patented graphene oxide bonding system. Studies show that less than .01% of the virus remains alive after contact with the graphene oxide enabled mask. The mask has earned a CE certification for meeting EU Standards, achieved a US Standard for a BFE of 99%, has an FDA Registration and has earned NSF Certification (National Sanitation Foundation, USA) and is accredited by ANSI (American National Standards Institute).
Adding to the graphene oxide story is the fact that two 2010 Nobel Prize in Physics winning scientists have been associated with the company and the development of the product since the company’s founding. See the link below for the full details on their groundbreaking experiments regarding the two dimensional material graphene oxide:
The “secret sauce” of the MyGO2Mask is two-fold; the quality of its patented graphene oxide and the unique and patented bonding mechanism used by the manufacturer that filters nearly 100% of particles .3 nanometers or smaller. Graphene has also proven to be electrostatic, dust repellant, waterproof and can be safely washed with warm water and soap up to 15x without compromising its integrity.
More information about the graphene oxide powered MyGO2Mask, including product certificates and supporting scientific studies can be found at www.mygo2mask.us.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
